Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Tomoko Narita"'
Autor:
Takuto Tachita, Masaki Ri, Sho Aoki, Arisa Asano, Takashi Kanamori, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Multiple myeloma (MM) is an incurable B‐cell malignancy often accompanied by profound immunodeficiency. Lenalidomide (Len) is an immunomodulatory drug that exerts promising therapeutic effects on MM through the immune system. However, pred
Externí odkaz:
https://doaj.org/article/5be8624e698c4954a681a98d8ab053ef
Autor:
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, Tomoyuki Nakamura, Yoshiaki Marumo, Kana Oiwa, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Atsushi Inagaki, Masaki Ri, Hirokazu Komatsu, Takashi Aritsu, Shinsuke Iida
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13135-13144 (2023)
Abstract Background The recently developed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mRNA vaccine has a short history of use and further information is needed regarding its efficacy, especially in immunocompromised conditions,
Externí odkaz:
https://doaj.org/article/250baa990edc4fb8b1c546d09c22e6aa
Autor:
Shinya Hagiwara, Masaki Ri, Arisa Asano, Ayako Masaki, Yoshiaki Marumo, Kentaro Hirade, Takahiro Nakashima, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Hirokazu Komatsu, Shinsuke Iida
Publikováno v:
HemaSphere, Vol 7, p e78173a1 (2023)
Externí odkaz:
https://doaj.org/article/86ed0d9618b84a4d82b86ee25417aa1c
Autor:
Tomoko Narita, Shunya Nakane, Akiko Nagaishi, Naoya Minami, Masaaki Niino, Naoki Kawaguchi, Hiroyuki Murai, Jun-ichi Kira, Jun Shimizu, Kazuo Iwasa, Hiroaki Yoshikawa, Yuki Hatanaka, Masahiro Sonoo, Yuko Shimizu, Hidenori Matsuo
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: Treatment for ocular myasthenia gravis (OMG) has not yet been well established. Few reports have been published on the clinical practice and outcomes of OMG. Objectives: We investigated treatment of OMG and its outcomes in Japan. Design:
Externí odkaz:
https://doaj.org/article/4502b9f6815f4854ba27c57f2bfaf18c
Autor:
Tomotaka Suzuki, Rui Yokomori, Takaomi Sanda, Takaki Kikuchi, Yoshiaki Marumo, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
We report a 69-year-old female who was a human T-cell leukemia virus type 1 carrier and exhibited a unique clinical course of developing three hematological malignancies within a short period: diffuse large B-cell lymphoma (DLBCL), chronic myelomonoc
Externí odkaz:
https://doaj.org/article/8aba716dd1a04644967bae0b971ebc08
Autor:
Takafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, Junki Yamamoto, Satoshi Osaga, Haruna Fujinami, Takaki Kikuchi, Tomotaka Suzuki, Haruhito Totani, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Kazuaki Wakami, Toshihiko Goto, Tomonori Sugiura, Yoshihiro Seo, Nobuyuki Ohte, Shinsuke Iida
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 498-506 (2020)
Abstract We investigated the incidence of cardiotoxicity, its risk factors, and the clinical course of cardiac function in patients with malignant lymphoma (ML) who received a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regime
Externí odkaz:
https://doaj.org/article/87ae7445493b4183952f1ca81d57c702
Autor:
Shiori Kinoshita, Takashi Ishida, Asahi Ito, Tomoko Narita, Ayako Masaki, Susumu Suzuki, Takashi Yoshida, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Norio Shimizu, Hiroshi Inagaki, Taruho Kuroda, Arne Scholz, Ryuzo Ueda, Takaomi Sanda, Shinsuke Iida
Publikováno v:
Haematologica, Vol 103, Iss 12 (2018)
BAY 1143572 is a highly selective inhibitor of cyclin-dependent kinase 9/positive transcription elongation factor b. It has entered phase I clinical studies. Here, we have assessed the utility of BAY 1143572 for treating natural killer (NK) cell leuk
Externí odkaz:
https://doaj.org/article/5d778fa3591e41a1a5a21debea8accc7
Autor:
Takashi Yoshida, Masaki Ri, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Reham Ashour, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196780 (2018)
Bortezomib (Btz) is an active agent used to treat multiple myeloma (MM). Not all patients who receive Btz-containing therapy show a favorable response. Interaction of cellular adhesion molecules with MM and bone marrow stromal cells is crucial for th
Externí odkaz:
https://doaj.org/article/d477ca8d874d486ca4a3f4e5f8141973
Autor:
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, Tomoyuki Nakamura, Yoshiaki Marumo, Kana Oiwa, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Atsushi Inagaki, Masaki Ri, Hirokazu Komatsu, Takashi Aritsu, Shinsuke Iida
Publikováno v:
International Journal of Hematology. 117:900-909
Autor:
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, Tomoyuki Nakamura, Yoshiaki Marumo, Kana Oiwa, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Atsushi Inagaki, Masaki Ri, Hirokazu Komatsu, Takashi Aritsu, Shinsuke Iida
Publikováno v:
Cancer Medicine.